Exogenous lysoPC altered transcriptomic profiles of lung cancer cells, of which ACSL5 was identified and validated as the target gene in lysoPC‐induced lung cancer cell hypoplasia and as a risk factor for lung cancer patient survival. Here, ACSL5 is linked to lung cancer.